This study demonstrated that blocking the CXCR4‐mediated JAK/STAT signaling pathway in astrocytes can improve the pathology of AD to a certain extent, which provided a new therapeutic avenue for the treatment of AD. The gene discussed is CXCR4; the disease is Alzheimer disease.